Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2005
06/07/2005US6903220 Synthesis of chiral 2-alkyl amino acids
06/07/2005US6903186 Analogues of GLP-1
06/07/2005US6903135 Methods and products related to 16-HETE analogs
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
06/07/2005US6903123 Antitussive agents, anxiolytic agents, analgesics for treating cough, anxiety and pain
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903096 Quinazoline derivatives as medicaments
06/07/2005US6903089 Lactam-substituted pyrazolopyridine derivatives
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/07/2005US6902742 Pulsatile delivery of methylphenidate to treat attention deficit disorder
06/07/2005CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives
06/07/2005CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
06/02/2005WO2005049631A1 Synthetic molecules having immune activity
06/02/2005WO2005034929A9 Tissue remodeling and vascularization
06/02/2005WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
06/02/2005US20050119450 Biodegradable polyphosphoramidates for controlled release of bioactive substances
06/02/2005US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
06/02/2005US20050119277 Benzazole derivatives for the treatment of scleroderma
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119196 Remedies for lung cancer
06/02/2005US20050118289 Process for producing fat composition containing hydrophobic components of glycyrrhiza
06/02/2005US20050118287 nasal or mouth spray; Extract of Alpinia galanga Rhizomes; Preferably, the vallinoid is selected from the group comprising capsaicin, piperine, gingerols and shogaols
06/02/2005US20050118195 Virus causing respiratory tract illness in susceptible mammals
06/02/2005US20050118109 Method for treating lung diseases associated with ventilation-perfusion mismatches
06/02/2005US20050118107 Formoterol combined with polyvinylpyrrolidone, polyethylene glycol, HFA 227 and HFA 134a; stable in pressurized meter dosage interior coated cans fitted with retention valve
06/02/2005CA2546028A1 Novel compounds
06/02/2005CA2545855A1 Alpha 1-antitrypsin compositions and treatment methods using such compositions
06/02/2005CA2545193A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/01/2005EP1535920A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
06/01/2005EP1535911A1 Metabolically inert anti-inflammatory and anti-tumor antifolates
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1534847A1 Retroviral vector and stable packaging cell lines
06/01/2005EP1534753A2 Antibody peg positional isomers, compositions comprising same, and use thereof
06/01/2005EP1534725A2 Compounds and methods for inhibiting selectin-mediated function
06/01/2005EP1534707A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
06/01/2005EP1534687A1 Pyrimidine compounds
06/01/2005EP1534677A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1
06/01/2005EP1534676A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
06/01/2005EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
06/01/2005EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
06/01/2005EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
06/01/2005EP1534368A1 Medicament dispenser
06/01/2005EP1534367A1 Medicament dispenser
06/01/2005EP1534329A2 Vaccine comprising il-13 and an adjuvant
06/01/2005EP1534327A2 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
06/01/2005EP1534323A2 Il-14 vaccine for the treatment of asthma and atopic disorders
06/01/2005EP1534300A2 3, 10, and 12a substituted tetracycline compounds
06/01/2005EP1534290A2 Novel inhibitors of kinases
06/01/2005EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders
06/01/2005EP1534282A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
06/01/2005EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
06/01/2005EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
06/01/2005EP1534272A2 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors
06/01/2005EP1534267A1 Pyrrolidine derivatives as tryptase inhibitors
06/01/2005EP1534251A1 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
06/01/2005EP1534250A2 Electrospun amorphous pharmaceutical compositions
06/01/2005EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
06/01/2005EP1423002A4 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent
06/01/2005EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors
06/01/2005EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
06/01/2005EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
06/01/2005EP1188754B1 Substituted pyrazole compounds
06/01/2005EP1178977B1 Ion channel modulating agents
06/01/2005EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
06/01/2005EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
06/01/2005EP1003744B1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
06/01/2005EP0794963B1 Xanthine derivatives compounds useful for activating chloride conductance in animal cells
06/01/2005CN1622994A TGF-beta-specific covalently closed antisense molecule
06/01/2005CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
06/01/2005CN1622938A 方法 Method
06/01/2005CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound
06/01/2005CN1622802A Composition for inhalation
06/01/2005CN1621417A Antibody against SARS-CoV IgY and its preparing method
06/01/2005CN1621415A Immunoglobulin antibody against SARS-CoV and its preparing method
06/01/2005CN1621094A Gene transfer for regulating smooth muscle tone
06/01/2005CN1621081A Preparation of isotomic injecta containing cordate houttuynia and honeysuckle flower and its preparation method
06/01/2005CN1621076A Plaster applied to navel for treating cold type asthma
06/01/2005CN1621064A Chinese medicine for treating wind-warm disease
06/01/2005CN1621057A Medicine for treating asthma
06/01/2005CN1621038A Usage of glanthidine, total alkali extract and preparation method and usage thereof
06/01/2005CN1621023A Sheep catghut soak
06/01/2005CN1620937A Pure traditional Chinese herbal drink preparation method
06/01/2005CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs.
06/01/2005CN1204135C 1, 3-dioxolanes with antitussive activity
06/01/2005CN1203885C Chinese patent medicine for treating infantile cough and asthma and preparation thereof
06/01/2005CN1203881C Medicine for curing cold and influenza and complication and its preparing process
06/01/2005CN1203875C Chinese herbal lozenge for treating laryngopharyngitis and its preparation method
06/01/2005CN1203873C Medicine for treating epistaxis
06/01/2005CN1203870C Medicament for treating chronic bronchitis and bronchial asthma and preparation method thereof
06/01/2005CN1203864C Spray formulation of providone iodine
06/01/2005CN1203854C Compositions having improved delivery of actives
06/01/2005CN1203852C Valdecoxib compositions
06/01/2005CN1203851C Use of inhibitor produced or released by reactive oxygen metablite in producing pharmaceutical
05/2005
05/31/2005US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/31/2005US6900338 Scavenger compounds
1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 878